Table 4. Vital signs analysis among both groups .
| Variables | Methocarbamol (no. 55) | Nefopam (no. 55) | P-value | |
| Systolic blood pressure | At administration (Mean ± SD) | 137.17±9.06 | 135.19±7.94 | 0.08 |
| After 1 hour (Mean ± SD) | 135.24±7.96 | 133.56±7.31 | 0.06 | |
| After 6 hours (Mean ± SD) | 138.29±5.46 | 137.64±6.21 | 0.064 | |
| After 12 hours (Mean ± SD) | 129.0±6.82 | 127.41±5.22 | 0.057 | |
| Diastolic blood pressure | At administration (Mean ± SD) | 83.96±6.40 | 85.56±8.22 | 0.421 |
| After 1 hour (Mean ± SD) | 82.83±7.50 | 84.70±8.81 | 0.058 | |
| After 6 hours (Mean ± SD) | 79.45±4.67 | 80.66±6.14 | 0.069 | |
| After 12 hours (Mean ± SD) | 81.94±5.99 | 77.92±6.44 | 0.052 | |
| Pulse rate | At administration (Mean ± SD) | 98.06±10.3 | 96.04±4.86 | 0.053 |
| After 1 hour (Mean ± SD) | 105.74±6.58 | 110.22±6.30 | 0.058 | |
| After 6 hours (Mean ± SD) | 99.32±7.05 | 108.81±9.97 | 0.031 | |
| After 12 hours (Mean ± SD) | 97.82±7.81 | 97.08±8.17 | 0.485 | |